P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis | Zendy

AI Assistant Blog Pricing

P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.